insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

EDAP · Edap Tms SA - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · EDAP

1Y3Y5YMax
Sign in to download
AnnualQuarterly

Income Statement

Line itemQ1 '26Q4 '25Q4 '24Q4 '23
Revenue$17.81M---
Cost of Revenue$8.27M---
Gross Profit$5.99M---
R&D$2.58M---
SG&A$3.65M---
Total Operating Expenses$12.30M---
D&A$753.0K---
Operating Income($6.31M)---
Interest Expense----
Income Tax$144.0K---
Net Income($9.08M)---
EPS - Basic($0.20)---
EPS - Diluted($0.20)---

Balance Sheet

Line itemQ1 '26Q4 '25Q4 '24Q4 '23
Cash & Equivalents$15.01M$20.45M$31.00M$48.03M
Accounts Receivable$19.65M$21.29M$19.32M-
Inventory$13.33M$12.83M$19.21M-
Accounts Payable-$11.72M$13.04M-
Current Assets$50.36M$57.16M$72.59M-
Total Assets$72.06M$79.00M$89.41M-
Current Liabilities$37.51M$37.14M$39.28M-
Long-term Debt$17.60M$15.90M$2.25M-
Total Liabilities$61.96M$59.58M$46.92M-
Stockholders' Equity$10.10M$19.41M$42.48M$62.90M
Retained Earnings($137.70M)($128.62M)($99.37M)-

Cash Flow

Line itemQ1 '26Q4 '25Q4 '24Q4 '23
Operating Cash Flow($5.34M)---
Investing Cash Flow($1.30M)---
Financing Cash Flow($1.25M)---
CapEx----
Free Cash Flow----

Ratios

MetricQ1 '26Q4 '25Q4 '24Q4 '23
Profitability
Gross margin33.6%---
Operating margin-35.4%---
EBITDA margin-31.2%---
Net margin-51.0%---
Free cash flow margin----
FCF / Net income----
R&D / Revenue14.5%---
SG&A / Revenue20.5%---
Effective tax rate----
Return on assets-12.6%---
Return on equity-89.9%---
Return on invested capital-18.0%---
Liquidity
Current ratio1.341.541.85-
Quick ratio0.991.191.36-
Cash ratio0.400.550.79-
Leverage
Debt / Equity1.740.820.05-
Debt / Assets0.240.200.03-
Debt / EBITDA----
Interest coverage----
Equity multiplier7.134.072.10-
Liabilities / Assets0.860.750.52-
Efficiency
Asset turnover0.25---
Inventory turnover0.62---
Days sales outstanding403d---
Days inventory outstanding588d---
Days payable outstanding----
Cash conversion cycle----
Valuation
P / E----
P / B13.8x---
P / S7.8x---
EV / EBITDA----
Growth
Revenue growth (YoY)----
Revenue CAGR (3y)----
Revenue CAGR (5y)----
Gross profit growth (YoY)----
Operating income growth (YoY)----
Net income growth (YoY)----
EPS growth (YoY)----
EPS CAGR (3y)----
EPS CAGR (5y)----
FCF growth (YoY)----
FCF CAGR (5y)----
Book value growth (YoY)--54.3%-32.5%-

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$70.53M total
High Intensity Focused Ultrasound HIFU$37.35M · 53.0%
Distribution Division$25.71M · 36.5%
Lithotripsy Eswl$7.46M · 10.6%

Product / service

$70.53M total
Manufactured Product Other$48.90M · 69.3%
Parts And Services$11.34M · 16.1%
HIFUTreatments And Devices Leased$10.29M · 14.6%

Geographic

$70.53M total
US$28.52M · 40.4%
Asia$19.57M · 27.7%
Other Geographical Areas$17.84M · 25.3%
FR$4.59M · 6.5%

Peer comparison

Same SIC group: Electromedical & Electrotherapeutic Apparatus

CompanyRevenue (last FY)Net marginROE
BLFS---1.2%
OM$119.48M-68.3%-64.3%
ITGR$1.85B5.5%5.9%
TMDX$605.49M31.4%40.2%
MDT---

Comparing EDAP TMS SA against the 5 most active filers in the same SIC group.